VERWENDUNG VON DAPTOMYCIN

European patent · EP1115417 · Deleted

Register entry

Publication number
EP1115417
Application number
EP99949913
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 24, 1999
Published
Jul 18, 2001
Granted
Apr 5, 2006
Deleted
Apr 5, 2006
Reason
Revoked in opposition
IPC classes
A61K 38/12 (2006.01)
Priority
US 101828 P 25.09.1998
US 125750 P 24.03.1999
PCT application
PCT/US1999/022366 24.09.1999
PCT publication
WO2000/018419 06.04.2000
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Daptomycinum

C01115417/01 · Medicine · Granted · Protection from Sep 24, 2019 to Apr 2, 2022

Authorisation 57870 (Swissmedic, Apr 3, 2007)

Deleted, Maximum term reached

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  2. Mar 30, 2018

    Change

    Published in Swissreg on 30.03.2018

  3. Sep 16, 2016

    Address changed

    Owner
    Cubist Pharmaceuticals LLC, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA → Cubist Pharmaceuticals LLC, Weystrasse 20, 6006 Luzern

    Published in Swissreg on 16.09.2016

  4. Dec 16, 2015

    Address changed

    Owner
    Cubist Pharmaceuticals LLC, 65 Hayden Avenue, Lexington, MA 02421, USA → Cubist Pharmaceuticals LLC, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA

    Published in Swissreg on 16.12.2015

  5. Dec 2, 2015

    Address changed

    Owner
    Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421, USA → Cubist Pharmaceuticals LLC, 65 Hayden Avenue, Lexington, MA 02421, USA

    Published in Swissreg on 02.12.2015

  6. Mar 15, 2011

    Address changed

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25 → BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 15.03.2011

  7. Jul 31, 2006

    Agent entered

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in +pat+ No 14 in 2006

  8. Apr 13, 2006

    Granted

    Published in +pat+ No 7 in 2006

Parties

Holder

Cubist Pharmaceuticals LLC

Weystrasse 20, 6006 Luzern

Agent

Bovard AG

BOVARD AG

Patent- und Markenanwälte Optingenstrasse 16, 3000 Bern 25

Inventor

OLESON, Frederick, B., Jr.

Concord, MA 01742, US

TALLY, Francis, P.

Lincoln, MA 01733, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.